AGRAWAL, A.; BHOSALE, U. A. A prospective pharmacovigilance study to evaluate adverse effect profile of first line anti-tubercular drugs in newly diagnosed sputum positive patients. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 7, n. 2, p. 283–287, 2018. DOI: 10.18203/2319-2003.ijbcp20180099. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/2237. Acesso em: 23 oct. 2025.